Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clinical Efficacy of Blood Ultrafiltration Therapy in Patients with Acute Decompensated Chronic Heart Failure Running Title: Blood Ultrafiltration Therapy for Heart Failure

YW. He, FQ. Wang, FF. Zhang, HZ. Chen

. 2023 ; 72 (6) : 701-706. [pub] 20231231

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24003174

In this study, we investigated the clinical effects of blood ultrafiltration therapy in patients with acute decompensated chronic heart failure. We enrolled 78 patients with acute decompensated chronic heart failure who were admitted to a hospital from September 2017 to December 2021, and divided them into two groups based on the digital randomization method. The FQ-16 heart failure ultrafiltration dehydrating device blood ultrafiltration therapy was administered to the observation group (39 patients) for 8-16 hours, while the control group (39 patients) received the stepped drug therapy. Echocardiography was used to assess the changes in cardiac function of the patients in both groups before and after treatment. The changes in urine volume, N-terminal pro-B-type natriuretic peptide (NT-proBNP), plasma renin, and serum creatinine levels were measured before and after the treatment to compare the overall response rate of the patients in both groups. The differences in left ventricular end-systolic dimension and left ventricular end-diastolic dimension and the ejection fraction between the groups before treatment were not statistically significant (P > 0.05), however, the left ventricular end-diastolic dimension in the observation group was significantly lower and the ejection fraction was significantly higher (P < 0.05) compared with that before treatment; the urine volume, N-terminal pro-B-type natriuretic peptide (NT-proBNP), plasma renin, and serum creatinine were significantly improved in both groups after treatment compared with that before treatment. All indexes in the observation group were better than those in the control group (P < 0.05), 74.36%. The overall response rate of the observation group was 94.87%, x2 = 4.843 and the difference between groups was statistically significant (P < 0.05). Blood ultrafiltration therapy for patients with acute decompensated chronic heart failure can improve their cardiac and renal functions, reduce NT-proBNP, reduce volume load, and enhance efficacy while ensuring high safety.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24003174
003      
CZ-PrNML
005      
20250416104649.0
007      
ta
008      
240220s2023 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.935073 $2 doi
035    __
$a (PubMed)38215058
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a He, Yan-Wei $u Department of Cardiology, The First People's Hospital of Yangquan, Yangquan, China
245    10
$a Clinical Efficacy of Blood Ultrafiltration Therapy in Patients with Acute Decompensated Chronic Heart Failure Running Title: Blood Ultrafiltration Therapy for Heart Failure / $c YW. He, FQ. Wang, FF. Zhang, HZ. Chen
520    9_
$a In this study, we investigated the clinical effects of blood ultrafiltration therapy in patients with acute decompensated chronic heart failure. We enrolled 78 patients with acute decompensated chronic heart failure who were admitted to a hospital from September 2017 to December 2021, and divided them into two groups based on the digital randomization method. The FQ-16 heart failure ultrafiltration dehydrating device blood ultrafiltration therapy was administered to the observation group (39 patients) for 8-16 hours, while the control group (39 patients) received the stepped drug therapy. Echocardiography was used to assess the changes in cardiac function of the patients in both groups before and after treatment. The changes in urine volume, N-terminal pro-B-type natriuretic peptide (NT-proBNP), plasma renin, and serum creatinine levels were measured before and after the treatment to compare the overall response rate of the patients in both groups. The differences in left ventricular end-systolic dimension and left ventricular end-diastolic dimension and the ejection fraction between the groups before treatment were not statistically significant (P > 0.05), however, the left ventricular end-diastolic dimension in the observation group was significantly lower and the ejection fraction was significantly higher (P < 0.05) compared with that before treatment; the urine volume, N-terminal pro-B-type natriuretic peptide (NT-proBNP), plasma renin, and serum creatinine were significantly improved in both groups after treatment compared with that before treatment. All indexes in the observation group were better than those in the control group (P < 0.05), 74.36%. The overall response rate of the observation group was 94.87%, x2 = 4.843 and the difference between groups was statistically significant (P < 0.05). Blood ultrafiltration therapy for patients with acute decompensated chronic heart failure can improve their cardiac and renal functions, reduce NT-proBNP, reduce volume load, and enhance efficacy while ensuring high safety.
650    _2
$a lidé $7 D006801
650    12
$a natriuretický peptid typu B $7 D020097
650    _2
$a ultrafiltrace $7 D014462
650    _2
$a renin $7 D012083
650    _2
$a kreatinin $7 D003404
650    12
$a srdeční selhání $7 D006333
650    _2
$a výsledek terapie $7 D016896
650    _2
$a diuretika $x terapeutické užití $7 D004232
650    _2
$a peptidové fragmenty $7 D010446
650    _2
$a tepový objem $x fyziologie $7 D013318
650    _2
$a funkce levé komory srdeční $x fyziologie $7 D016277
650    _2
$a biologické markery $7 D015415
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wang, Feng-Qin $u Department of Cardiology, The First People's Hospital of Yangquan, Yangquan, China
700    1_
$a Zhang, Fen-Fang $u Department of Cardiology, The First People's Hospital of Yangquan, Yangquan, China
700    1_
$a Chen, Huan-Zhen $u Department of Cardiology, The First People's Hospital of Yangquan, Yangquan, China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, č. 6 (2023), s. 701-706
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38215058 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20240220 $b ABA008
991    __
$a 20250416104654 $b ABA008
999    __
$a ok $b bmc $g 2302953 $s 1212914
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 72 $c 6 $d 701-706 $e 20231231 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
LZP    __
$b NLK116 $a Pubmed-20240220

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...